Alectinib(CH5424802) Catalog No : 51907

Product Name	Alectinib(CH5424802)
Iupac Chemical Name	9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Synonyms	Alectinib;CH5424802;CH-5424802;CH 5424802
Molecular Formula	C30H34N4O2
Molecular Weight	482.62
Smile	C(C)C1=CC2=C(C(C=3NC4=CC(=CC=C4C3C2=O)C#N)(C)C)C=C1N1CCC(CC1)N1CCOCC1
InChiKey	KDGFLJKFZUIJMX-UHFFFAOYSA-N
InChi	InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3
Cas	1256580-46-7

Appearance	off-white solid
Purity	98.5% by HPLC
Solubility	2mg/ml in DMSO
Storage	3 years -20ºCpowder
Shipping Condition	Shipped under ambient temperature.
Quality control	HNMR HPLC

Alectinib is a second-generation, orally active, potent and highly selective inhibitor of anaplastic lymphoma kinase (ALK). Alectinib is approved for the treatment of ALK fusion-gene positive, unresectable, advanced or recurrent non-small cell lung cancer (NSCLC) in Japan, where it has been given orphan drug designation.

Alectinib(CH5424802) Catalog No : 51907

Chemical Information

Technical Data

Description

Chemical Structure

Package

Quick Order

Contact Us